Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

International standards for the analysis of quality-of-life and patient-reported outcome endpoints in cancer randomised controlled trials: recommendations of the SISAQOL Consortium

Research output: Contribution to journalReviewResearchpeer-review

  1. Entrectinib for ROS1 fusion-positive NSCLC and NTRK fusion-positive solid tumours

    Research output: Contribution to journalComment/debateResearchpeer-review

  2. The incomplete story of complete mesocolic excision - Authors' reply

    Research output: Contribution to journalLetterResearch

  3. 5-year outcome after complete mesocolic excision for right-sided colon cancer: a population-based cohort study

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Access to radiotherapy among circumpolar Inuit populations

    Research output: Contribution to journalReviewResearchpeer-review

  1. International validation of the EORTC CAT Core: a new adaptive instrument for measuring core quality of life domains in cancer

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Integration af specialiseret palliation og onkologi

    Research output: Contribution to journalJournal articleResearchpeer-review

  • Setting International Standards in Analyzing Patient-Reported Outcomes and Quality of Life Endpoints Data Consortium
View graph of relations

Patient-reported outcomes (PROs), such as symptoms, function, and other health-related quality-of-life aspects, are increasingly evaluated in cancer randomised controlled trials (RCTs) to provide information about treatment risks, benefits, and tolerability. However, expert opinion and critical review of the literature showed no consensus on optimal methods of PRO analysis in cancer RCTs, hindering interpretation of results. The Setting International Standards in Analyzing Patient-Reported Outcomes and Quality of Life Endpoints Data Consortium was formed to establish PRO analysis recommendations. Four issues were prioritised: developing a taxonomy of research objectives that can be matched with appropriate statistical methods, identifying appropriate statistical methods for PRO analysis, standardising statistical terminology related to missing data, and determining appropriate ways to manage missing data. This Policy Review presents recommendations for PRO analysis developed through critical literature reviews and a structured collaborative process with diverse international stakeholders, which provides a foundation for endorsement; ongoing developments of these recommendations are also discussed.

Original languageEnglish
JournalLancet Oncology
Volume21
Issue number2
Pages (from-to)e83-e96
Number of pages14
ISSN1470-2045
DOIs
Publication statusPublished - Feb 2020

ID: 59912774